LABOMAR CANADA
Maxime Lamontagne, B.Sc., Mcb.A., serves as Directeur qualité at LABOMAR CANADA since February 2025. Prior to this role, Maxime accumulated extensive experience at Jubilant HollisterStier CMO, holding various positions from November 2009 to February 2025, including Directeur Associé, Qualité et Conformité, and Senior Manager of Quality Operations and Compliance. Earlier career achievements include positions at KABS Laboratories Inc. as a Microbiologiste from September 2007 to November 2009. Maxime's educational background includes a Baccalauréat in Microbiologie from Université Laval and a DEC in Sciences pures et appliquées from Collège Champlain St-Lawrence.
This person is not in any teams
This person is not in any offices
LABOMAR CANADA
We are committed to contributing to society’s better health. Established in 1990 in Montreal, Canada, we are a pharmaceutical company with more than 30 years’ experience in the manufacturing of semi-solid (creams, ointments, gels, lotions) and liquid products. Our core business area is the development, production and packaging of top-quality products for the pharmaceutical, cosmetic and nutraceutical industry. The Company became part of the Labomar Group in 2019 and in 2023 changes its business name to Labomar Canada. Our mission is to provide customer-driven manufacturing services of the highest quality with products that will meet and exceed current and evolving client’s expectations. Our objective is to maintain our position as a reliable reference point in the manufacturing of quality pharmaceutical products: essentially, a benchmark for modern, efficient production, assured through the use of highly performing equipment. Labomar Canada offers manufacturing capabilities ranging from laboratory to pilot batches to scale-ups. The facilities are approved and inspected by Health Canada and FDA and registered under accredited GMP pharmaceutical standards.